Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.40B
Revenue (ttm)	1.77B
Net Income (ttm)	324.56M
Shares Out	177.68M
EPS (ttm)	1.82
PE Ratio	7.40
Forward PE	7.81
Dividend	0.36 (2.70%)
Ex-Dividend Date	Dec 5, 2025

Volume	516,500
Average Volume	279,320
Open	13.50
Previous Close	13.48
Day's Range	12.73 - 13.50
52-Week Range	11.48 - 14.76
Beta	0.40
RSI	66.30
Earnings Date	Feb 20, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.